Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Novel blood test for the early detection of oral, prostate and breast cancer

30.01.2014
The likelihood for successful treatment of a cancer is fundamentally linked to an early diagnosis of the condition.

For this, it is essential to provide tests that allow early detection of cancer without the need of a tissue sample, and thus drastically improve the prognosis of the patients and their chance of a cure. Currently established cancer diagnostics either identify the disease too late or are unreliable, resulting in false positives, which can unsettle patients.

For instance, measuring PSA-levels for prostate cancer detection and mammographies for breast cancer prevention can provide false positive results without acute malignancies being found. Additionally, currently no blood test is available for oral cancer.

A novel blood test for the detection of cancer has been clinically assessed in a collaborative study between the university hospital Tuebingen, the German Cancer Research Center in Heidelberg, and the Clemenshospital of the university hospital muenster. This blood test utilizes the immune system; specifically the activity of macrophages, a type of white blood cell that scavenges tumor cells.

Using laser-based detection methods of tumor material within these scavenger cells, also known as EDIM (epitope detection in monocytes)-technology, it is now possible to discover the presence of tumor cells in small blood samples. This has allowed the early detection of oral, prostate, and breast cancer as well as relapses in patients by the EDIM-technology. Thus, this technology is also suitable for monitoring therapeutic efficacy. The results of this study represent an important hallmark in cancer detection, driven by the improved accuracy of the EDIM-blood test compared to previously established test methodologies.

publication

A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells
Martin Grimm, Steffen Schmitt, Peter Teriete, Thorsten Biegner, Arnulf Stenzl, Jörg Hennenlotter, Hans-Joachim Muhs, Adelheid Munz, Tatjana Nadtotschi, Klemens König, Jörg Sänger, Oliver Feyen, Heiko Hofmann, Siegmar Reinert and Johannes F Coy
BMC Cancer 2013, 13:569 - doi:10.1186/1471-2407-13-569
Quelle: http://www.biomedcentral.com/1471-2407/13/569
Contact
Universitätsklinikum Tübingen
Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie
Priv.-Doz. Dr. Dr. Martin Grimm
Osianderstr. 2-8, 72076 Tübingen
E-Mail: Martin.Grimm@med.uni-tuebingen.de

Dr. Ellen Katz | idw
Further information:
http://www.uni-tuebingen.de

More articles from Health and Medicine:

nachricht Location of body fat can increase hypertension risk
02.09.2014 | American College of Cardiology

nachricht New tuberculosis blood test in children is reliable and highly specific
01.09.2014 | Swiss Tropical and Public Health Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

IT security in the digital society

27.08.2014 | Event News

Understanding the brain—neuroscientists meet in Göttingen

27.08.2014 | Event News

MEDICA EDUCATION CONFERENCE: Bessere Behandlung dank Biomarker

21.08.2014 | Event News

 
Latest News

A smart fluorescent antenna for Wi-Fi applications

02.09.2014 | Power and Electrical Engineering

Blowfly maggots provide physical evidence for forensic cases

02.09.2014 | Life Sciences

Single laser stops molecular tumbling motion instantly

02.09.2014 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>